The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sudhir Sethi, the main promoter of Beryl Drugs Limited, has acquired 15,000 equity shares of the company through an open market transaction on 12 March 2026. This represents 0.29% of the company's total share capital, raising his holding from 4,55,143 shares (8.98%) to 4,70,143 shares (9.27%). The disclosure was filed under Regulation 29(2) of the SEBI Takeover Regulations, 2011. The total equity share capital of the company remains unchanged at 50,71,700 shares.
This is a small but positive signal — the promoter is increasing his personal stake in the company via open market purchase, indicating insider confidence. With holding now at 9.27%, the promoter is approaching the 10% mark, after which additional acquisition rules under SEBI takeover regulations would apply.